319 related articles for article (PubMed ID: 16288044)
1. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox.
Mahajan NP; Whang YE; Mohler JL; Earp HS
Cancer Res; 2005 Nov; 65(22):10514-23. PubMed ID: 16288044
[TBL] [Abstract][Full Text] [Related]
2. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
3. Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.
Mahajan K; Mahajan NP
J Cell Physiol; 2010 Aug; 224(2):327-33. PubMed ID: 20432460
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
5. Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis.
Choi HJ; Park JH; Park JH; Lee KB; Oh SM
FEBS Lett; 2015 Dec; 589(24 Pt B):3977-88. PubMed ID: 26592150
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling.
Zhang H; Tian Y; Shen J; Wang Y; Xu Y; Wang Y; Han Z; Li X
Int J Oncol; 2014 Aug; 45(2):719-31. PubMed ID: 24899407
[TBL] [Abstract][Full Text] [Related]
8. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
[TBL] [Abstract][Full Text] [Related]
9. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
[TBL] [Abstract][Full Text] [Related]
10. HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3.
Mahendrarajah N; Borisova ME; Reichardt S; Godmann M; Sellmer A; Mahboobi S; Haitel A; Schmid K; Kenner L; Heinzel T; Beli P; Krämer OH
Cell Signal; 2017 Nov; 39():9-17. PubMed ID: 28739485
[TBL] [Abstract][Full Text] [Related]
11. Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.
Shen F; Lin Q; Gu Y; Childress C; Yang W
Mol Biol Cell; 2007 Mar; 18(3):732-42. PubMed ID: 17182860
[TBL] [Abstract][Full Text] [Related]
12. Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
Qin HR; Kim HJ; Kim JY; Hurt EM; Klarmann GJ; Kawasaki BT; Duhagon Serrat MA; Farrar WL
Cancer Res; 2008 Oct; 68(19):7736-41. PubMed ID: 18829527
[TBL] [Abstract][Full Text] [Related]
13. Activity of the nonreceptor tyrosine kinase Ack1 is regulated by tyrosine phosphorylation of its Mig6 homology region.
Kan Y; Miller WT
FEBS Lett; 2022 Nov; 596(21):2808-2820. PubMed ID: 36178070
[TBL] [Abstract][Full Text] [Related]
14. The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation.
Chan W; Sit ST; Manser E
Biochem J; 2011 Apr; 435(2):355-64. PubMed ID: 21309750
[TBL] [Abstract][Full Text] [Related]
15. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.
Buchwald M; Pietschmann K; Brand P; Günther A; Mahajan NP; Heinzel T; Krämer OH
Oncogene; 2013 Oct; 32(41):4913-20. PubMed ID: 23208506
[TBL] [Abstract][Full Text] [Related]
16. Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.
Mahajan K; Challa S; Coppola D; Lawrence H; Luo Y; Gevariya H; Zhu W; Chen YA; Lawrence NJ; Mahajan NP
Prostate; 2010 Sep; 70(12):1274-85. PubMed ID: 20623637
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
18. ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.
Mahajan K; Mahajan NP
Oncogene; 2015 Aug; 34(32):4162-7. PubMed ID: 25347744
[TBL] [Abstract][Full Text] [Related]
19. WWOX suppresses prostate cancer cell progression through cyclin D1-mediated cell cycle arrest in the G1 phase.
Lin JT; Li HY; Chang NS; Lin CH; Chen YC; Lu PJ
Cell Cycle; 2015; 14(3):408-16. PubMed ID: 25659037
[TBL] [Abstract][Full Text] [Related]
20. Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells.
Mahajan NP; Coppola D; Kim J; Lawrence HR; Lawrence NJ; Mahajan K
Sci Rep; 2018 Jan; 8(1):1954. PubMed ID: 29386546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
